Danaher (DHR) 10-Q 17 Oct 13 2013 Q3 Quarterly report Financial data

Document_And_Entity_Informatio

Document And Entity Information	3 Months Ended
	Sep. 27, 2013	Oct. 11, 2013
Document And Entity Information [Abstract]
Document Type	10-Q
Amendment Flag	FALSE
Document Period End Date	27-Sep-13
Document Fiscal Year Focus	2013
Document Fiscal Period Focus	Q3
Trading Symbol	dhr
Entity Registrant Name	DANAHER CORP /DE/
Entity Central Index Key	313616
Current Fiscal Year End Date	-19
Entity Filer Category	Large Accelerated Filer
Entity Common Stock, Shares Outstanding		697,199,830

Consolidated_Condensed_Balance

Consolidated Condensed Balance Sheets (USD $)	Sep. 27, 2013	Dec. 31, 2012
In Millions, unless otherwise specified
Current Assets:
Cash and equivalents	$1,995.60	$1,678.70
Trade accounts receivable, net	3,372.70	3,267.30
Inventories:
Finished goods	983.6	899.9
Work in process	332.6	291.2
Raw materials	649.5	622.3
Total inventories	1,965.70	1,813.40
Prepaid expenses and other current assets	689.7	828.4
Total current assets	8,023.70	7,587.80
Property, plant and equipment, net of accumulated depreciation of $2,262.1 and $1,962.3, respectively	2,179.20	2,140.90
Investment in joint venture	0	548.3
Other assets	1,149.40	858
Goodwill	16,024.40	15,462
Other intangible assets, net	6,344.50	6,344
Total assets	33,721.20	32,941
Current Liabilities:
Notes payable and current portion of long-term debt	56.5	55.5
Trade accounts payable	1,683.60	1,546.30
Accrued expenses and other liabilities	2,539.30	2,604.30
Total current liabilities	4,279.40	4,206.10
Other long-term liabilities	4,625.50	4,363.40
Long-term debt	3,445.50	5,287.60
Stockholders' Equity:
Common stock - $0.01 par value	7.8	7.7
Additional paid-in capital	4,088.50	3,688.10
Retained earnings	17,233.50	15,379.90
Accumulated other comprehensive income (loss)	-25.2	-59.2
Total Danaher stockholders' equity	21,304.60	19,016.50
Non-controlling interests	66.2	67.4
Total stockholders' equity	21,370.80	19,083.90
Total liabilities and stockholders' equity	$33,721.20	$32,941

Consolidated_Condensed_Balance1

Consolidated Condensed Balance Sheets (Parenthetical) (USD $)	Sep. 27, 2013	Dec. 31, 2012
In Millions, except Per Share data, unless otherwise specified
Property, plant and equipment, accumulated depreciation	$2,262.10	$1,962.30
Common stock, par value (dollars per share)	$0.01	$0.01

Consolidated_Condensed_Stateme

Consolidated Condensed Statements Of Earnings (USD $)	3 Months Ended		9 Months Ended
In Millions, except Per Share data, unless otherwise specified	Sep. 27, 2013	Sep. 28, 2012	Sep. 27, 2013	Sep. 28, 2012
Sales	$4,669.10	$4,415.50	$13,851.30	$13,285.20
Cost of sales	-2,244.40	-2,137.50	-6,605.40	-6,416.20
Gross profit	2,424.70	2,278	7,245.90	6,869
Operating costs and other:
Selling, general and administrative expenses	-1,303.20	-1,251.20	-3,941.30	-3,774.70
Research and development expenses	-309.1	-289.5	-917.7	-843.2
Earnings from unconsolidated joint venture	0	18.5	0	50.9
Operating profit	812.4	755.8	2,386.90	2,302
Non-operating income (expense):
Gain on sale of unconsolidated joint venture	0	0	229.8	0
Interest expense	-35	-39.4	-113.6	-116.7
Interest income	1.4	0.7	3.9	2.1
Earnings from continuing operations before income taxes	778.8	717.1	2,507	2,187.40
Income taxes	-181.8	-168.4	-601.3	-518.5
Net earnings from continuing operations	597	548.7	1,905.70	1,668.90
Earnings from discontinued operations, net of income taxes	0	0	0	92.9
Net earnings	$597	$548.70	$1,905.70	$1,761.80
Net earnings per share from continuing operations:
Basic (dollars per share)	$0.86	$0.79	$2.74	$2.40
Diluted (dollars per share)	$0.84	$0.77	$2.69	$2.34
Net earnings per share from discontinued operations:
Basic (dollars per share)	$0	$0	$0	$0.13
Diluted (dollars per share)	$0	$0	$0	$0.13
Net earnings per share:
Basic (dollars per share)	$0.86	$0.79	$2.74	$2.54
Diluted (dollars per share)	$0.84	$0.77	$2.69	$2.47
Average common stock and common equivalent shares outstanding:
Basic (shares)	697.7	695.2	695	694.1
Diluted (shares)	711.9	713.9	710.1	714.3

Consolidated_Condensed_Stateme1

Consolidated Condensed Statements Of Comprehensive Income (USD $)	3 Months Ended		9 Months Ended
In Millions, unless otherwise specified	Sep. 27, 2013	Sep. 28, 2012	Sep. 27, 2013	Sep. 28, 2012
Net earnings	$597	$548.70	$1,905.70	$1,761.80
Other comprehensive income (loss), net of income taxes:
Foreign currency translation adjustments	288.2	193.5	-97.4	93.4
Pension and post-retirement plan benefit adjustments	5.5	8.1	16.5	21
Unrealized gain on available-for-sale securities	59.7	23.2	114.9	72.4
Total other comprehensive income, net of income taxes	353.4	224.8	34	186.8
Comprehensive income	$950.40	$773.50	$1,939.70	$1,948.60

Consolidated_Condensed_Stateme2

Consolidated Condensed Statement Of Stockholders' Equity (USD $)	Total	Common Stock	Additional Paid-In Capital	Retained Earnings	Accumulated Other Comprehensive Income (Loss)	Non-Controlling Interests
In Millions, unless otherwise specified
Balance, December 31, 2012, value at Dec. 31, 2012	$19,083.90	$7.70	$3,688.10	$15,379.90	($59.20)	$67.40
Balance, December 31, 2012, shares at Dec. 31, 2012		774.6
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Net earnings for the period	1,905.70			1,905.70
Other comprehensive income	34				34
Dividends declared				-52.1
Common stock based award activity, value		0.1	234.3
Common stock based award activity, shares		5.6
Common stock issued in connection with LYONs' conversions including tax benefit of $40.7, value		0	166.1
Common stock issued in connection with LYONs' conversions including tax benefit of $40.7, shares		4.4
Change in non-controlling interests						-1.2
Balance, September 27, 2013, value at Sep. 27, 2013	$21,370.80	$7.80	$4,088.50	$17,233.50	($25.20)	$66.20
Balance, September 27, 2013, shares at Sep. 27, 2013		784.6

Consolidated_Condensed_Stateme3

Consolidated Condensed Statement Of Stockholders' Equity (Parenthetical) (USD $)	9 Months Ended
In Millions, unless otherwise specified	Sep. 27, 2013
Common stock issued in connection with LYONs' conversions, tax benefit	$40.70

Consolidated_Condensed_Stateme4

Consolidated Condensed Statements Of Cash Flows (USD $)	9 Months Ended
In Millions, unless otherwise specified	Sep. 27, 2013	Sep. 28, 2012	Sep. 28, 2012
			ASI And KEO
Cash flows from operating activities:
Net earnings	$1,905.70	$1,761.80
Less: earnings from discontinued operations, net of income taxes	0	92.9
Net earnings from continuing operations	1,905.70	1,668.90
Non-cash items:
Depreciation	390.4	368.5
Amortization	271.3	251.9
Stock compensation expense	85.7	79.4
Earnings from unconsolidated joint venture, net of cash dividends received	66.6	-31.5
Pre-tax gain on sale of unconsolidated joint venture	-229.8	0
Change in trade accounts receivable, net	-5.4	134.5
Change in inventories	-119	-53.5
Change in trade accounts payable	99.7	38.5
Change in prepaid expenses and other assets	157.3	110.1
Change in accrued expenses and other liabilities	-115.4	104.5
Total operating cash provided by continuing operations	2,507.10	2,671.30
Total operating cash used in discontinued operations	0	-56
Net cash provided by operating activities	2,507.10	2,615.30
Cash flows from investing activities:
Cash paid for acquisitions	-868.6	-972.8
Payments for additions to property, plant and equipment	-391.8	-333.4
Proceeds from sale of unconsolidated joint venture	692	0
All other investing activities	-3.6	23.2
Total investing cash used in continuing operations	-572	-1,283
Proceeds from sale of discontinued operations	0	337.5
Net cash used in investing activities	-572	-945.5
Cash flows from financing activities:
Proceeds from the issuance of common stock	148.7	143.2
Payment of dividends	-34.7	-52
Purchase of stock	0	-258.5
Net repayments of borrowings (maturities of 90 days or less)	-768	-495
Repayments of borrowings (maturities longer than 90 days)	-966.9	-3.4
Net cash used in financing activities	-1,620.90	-665.7
Effect of exchange rate changes on cash and equivalents	2.7	0.2
Net change in cash and equivalents	316.9	1,004.30
Beginning balance of cash and equivalents	1,678.70	537
Ending balance of cash and equivalents	1,995.60	1,541.30
Supplemental disclosures:
Cash interest payments	127.3	126.9
Cash income tax payments (including $41 million for the nine month period ended September 28, 2012 related to the gain on sale of discontinued operations - refer to Note 3)	$351	$226.20	$41

General

General	9 Months Ended
	Sep. 27, 2013
Organization, Consolidation and Presentation of Financial Statements [Abstract]
General	GENERAL
	The consolidated condensed financial statements included herein have been prepared by Danaher Corporation (the “Company”) without audit, pursuant to the rules and regulations of the Securities and Exchange Commission. Certain information and footnote disclosures normally included in financial statements prepared in accordance with accounting principles generally accepted in the United States have been condensed or omitted pursuant to such rules and regulations; however, the Company believes that the disclosures are adequate to make the information presented not misleading. The condensed financial statements included herein should be read in conjunction with the financial statements as of and for the year ended December 31, 2012 and the Notes thereto included in the Company’s 2012 Annual Report on Form 10-K.
	In the opinion of the registrant, the accompanying financial statements contain all adjustments (consisting of only normal recurring accruals) necessary to present fairly the financial position of the Company as of September 27, 2013 and December 31, 2012, and its results of operations for the three and nine months ended September 27, 2013 and September 28, 2012 and its cash flows for each of the nine month periods then ended.
	Accumulated Other Comprehensive Income (Loss) - Effective January 1, 2013, the Company adopted accounting guidance that requires the Company to separately disclose, on a prospective basis, the change in each component of other comprehensive income (loss) relating to reclassification adjustments and current period other comprehensive income (loss). Foreign currency translation adjustments are generally not adjusted for income taxes as they relate to indefinite investments in non-U.S. subsidiaries. The changes in accumulated other comprehensive income (loss) by component for the three and nine months ended September 27, 2013 and September 28, 2012 are summarized below ($ in millions).
		Foreign			Pension and post-retirement plan benefit adjustments				Unrealized			Total
		currency							gain on
		translation							available-for-
		adjustments							sale securities
	For the Three Months Ended September 27, 2013:
	Balance, June 28, 2013	$	89.7		$	(644.7	)		$	176.4		$	(378.6	)
	Other comprehensive income (loss) before reclassifications:
	Pre-tax income	288.2			—				95.4			383.6
	Income tax expense	—			—				(35.7		)	(35.7		)
	Other comprehensive income (loss) before reclassifications, net of income taxes	288.2			—				59.7			347.9
	Amounts reclassified from accumulated other comprehensive income (loss):
	Pre-tax income	—			8.4			-1	—			8.4
	Income tax expense	—			(2.9		)		—			(2.9		)
	Amounts reclassified from accumulated other comprehensive income (loss), net of income taxes	—			5.5				—			5.5
	Net current period other comprehensive income, net of income taxes	288.2			5.5				59.7			353.4
	Balance, September 27, 2013	$	377.9		$	(639.2	)		$	236.1		$	(25.2	)
	(1) This accumulated other comprehensive income (loss) component is included in the computation of net periodic pension cost (refer to Note 8 for additional details).
		Foreign			Pension and post-retirement plan benefit adjustments				Unrealized			Total
		currency							gain on
		translation							available-for-
		adjustments							sale securities
	For the Three Months Ended September 28, 2012:
	Balance, June 29, 2012	$	284.4		$	(503.1	)		$	143.8		$	(74.9	)
	Net current period other comprehensive income (loss):
	Pre-tax income	193.5			12.7				37.2			243.4
	Income tax expense	—			(4.6		)		(14.0		)	(18.6		)
	Net current period other comprehensive income, net of income taxes	193.5			8.1				23.2			224.8
	Balance, September 28, 2012	$	477.9		$	(495.0	)		$	167		$	149.9
	For the Nine Months Ended September 27, 2013:
	Balance, December 31, 2012	$	475.3		$	(655.7	)		$	121.2		$	(59.2	)
	Other comprehensive income (loss) before reclassifications:
	Pre-tax income (loss)	(97.4		)	—				183.8			86.4
	Income tax expense	—			—				(68.9		)	(68.9		)
	Other comprehensive income (loss) before reclassifications, net of income taxes	(97.4		)	—				114.9			17.5
	Amounts reclassified from accumulated other comprehensive income (loss):
	Pre-tax income	—			25.2			-1	—			25.2
	Income tax expense	—			(8.7		)		—			(8.7		)
	Amounts reclassified from accumulated other comprehensive income (loss), net of income taxes	—			16.5				—			16.5
	Net current period other comprehensive income (loss), net of income taxes	(97.4		)	16.5				114.9			34
	Balance, September 27, 2013	$	377.9		$	(639.2	)		$	236.1		$	(25.2	)
	For the Nine Months Ended September 28, 2012:
	Balance, December 31, 2011	$	384.5		$	(516.0	)		$	94.6		$	(36.9	)
	Net current period other comprehensive income (loss):
	Pre-tax income	93.4			33				115.9			242.3
	Income tax expense	—			(12.0		)		(43.5		)	(55.5		)
	Net current period other comprehensive income, net of income taxes	93.4			21				72.4			186.8
	Balance, September 28, 2012	$	477.9		$	(495.0	)		$	167		$	149.9
	(1) This accumulated other comprehensive income (loss) component is included in the computation of net periodic pension cost (refer to Note 8 for additional details).

Acquisitions

Acquisitions	9 Months Ended
	Sep. 27, 2013
Business Combinations [Abstract]
Acquisitions	ACQUISITIONS
	The Company continually evaluates potential acquisitions that either strategically fit with the Company’s existing portfolio or expand the Company’s portfolio into a new and attractive business area. The Company has completed a number of acquisitions that have been accounted for as purchases and have resulted in the recognition of goodwill in the Company’s financial statements. This goodwill arises because the purchase prices for these businesses reflect a number of factors including the future earnings and cash flow potential of these businesses, the multiple to earnings, cash flow and other factors at which similar businesses have been purchased by other acquirers, the competitive nature of the processes by which the Company acquired the businesses and the complementary strategic fit and resulting synergies these businesses bring to existing operations.
	The Company makes an initial allocation of the purchase price at the date of acquisition based upon its understanding of the fair value of the acquired assets and assumed liabilities. The Company obtains this information during due diligence and through other sources. In the months after closing, as the Company obtains additional information about these assets and liabilities, including through tangible and intangible asset appraisals, and learns more about the newly acquired business, it is able to refine the estimates of fair value and more accurately allocate the purchase price. Only items identified as of the acquisition date are considered for subsequent adjustment. The Company is continuing to evaluate certain pre-acquisition contingencies associated with certain of its 2013 and 2012 acquisitions and is also in the process of obtaining valuations of acquired intangible assets and certain acquisition related liabilities in connection with these acquisitions. The Company will make appropriate adjustments to the purchase price allocation prior to completion of the respective measurement period, as required. The Company evaluated whether any adjustments to the prior periods' purchase price allocations were material and concluded no retrospective adjustment to prior period financial statements was required.
	For a description of the Company’s acquisition activity for the year ended December 31, 2012, reference is made to the financial statements as of and for the year ended December 31, 2012 and Note 2 thereto included in the Company’s 2012 Annual Report on Form 10-K.
	During the first nine months of 2013, the Company acquired eleven businesses for total consideration of $869 million in cash, net of cash acquired. The businesses acquired complement existing units of the Industrial Technologies, Life Sciences & Diagnostics, Environmental and Test & Measurement segments. The aggregate annual sales of the eleven acquired businesses at the time of their respective acquisitions, in each case based on the acquired company’s revenues for its last completed fiscal year prior to the acquisition, were $294 million. The Company preliminarily recorded an aggregate of $554 million of goodwill related to these acquisitions.
	The following table summarizes the estimated fair values of the assets acquired and liabilities assumed at the date of acquisition for all acquisitions consummated during the nine months ended September 27, 2013 ($ in millions):
	Trade accounts receivable	$	78.1
	Inventories	22.5
	Property, plant and equipment	47.5
	Goodwill	554
	Other intangible assets, primarily trade names, customer relationships and patents	343.4
	Trade accounts payable	(24.9		)
	Other assets and liabilities, net	(130.5		)
	Assumed debt	(21.2		)
	Non-controlling interest acquired	(0.3		)
	Net cash consideration	$	868.6
	Pro Forma Financial Information
	The unaudited pro forma information for the periods set forth below gives effect to the 2013 and 2012 acquisitions as if they had occurred as of January 1, 2012. The pro forma information is presented for informational purposes only and is not necessarily indicative of the results of operations that actually would have been achieved had the acquisitions been consummated as of that time ($ in millions, except per share amounts):
		Three Months Ended					Nine Months Ended
		September 27, 2013			September 28, 2012		September 27, 2013		September 28, 2012
	Sales	$	4,679.90		$	4,558.90	$	13,978.60	$	13,771.90
	Net earnings from continuing operations	596.5			551.3		1,907.50		1,685.10
	Diluted net earnings per share from continuing operations	$	0.84		$	0.77	$	2.69	$	2.37

Sale_of_Joint_Venture

Sale of Joint Venture	9 Months Ended
	Sep. 27, 2013
Equity Method Investments and Joint Ventures [Abstract]
Equity Method Investments and Joint Ventures Disclosure	SALE OF JOINT VENTURE
	On July 4, 2010, the Company entered into a joint venture with Cooper Industries, plc (“Cooper”), combining certain of the Company's hand tool businesses with Cooper's Tools business to form a new entity called Apex Tool Group, LLC (“Apex”). During the period that Cooper and the Company owned Apex, each of Cooper and the Company owned a 50% interest in Apex and had an equal number of representatives on Apex's Board of Directors. Neither joint venture partner controlled the significant operating and financing activities of Apex. The Company accounted for its investment in the joint venture based on the equity method of accounting.
	In February 2013, the Company and Cooper sold Apex to an unrelated third party for approximately $1.6 billion. The Company received $797 million from the sale, consisting of cash of $759 million and a note receivable of $38 million. The Company recognized an after-tax gain of $144 million or $0.20 per diluted share in its first quarter 2013 results in connection with this transaction. The gain is computed as the difference between the book value of the Company's investment in Apex at the time of sale and the fair value of the consideration received in exchange, as indicated in the table below ($ in millions):
	Fair value of consideration received:
	Cash, including $66.6 of dividends received during 2013 prior to the closing of the sale	$	758.6
	Note receivable	38.5
	Total fair value of consideration received	797.1
	Less book value of investment in unconsolidated joint venture	545.6
	Less other related costs and expenses	21.7
	Pre-tax gain on sale of unconsolidated joint venture	229.8
	Income tax expense	86.2
	After-tax gain on sale of unconsolidated joint venture	$	143.6
	The Company's share of the 2013 earnings generated by Apex prior to the closing of the sale was insignificant. The Company recorded $19 million and $51 million related to its equity in the earnings of Apex during the three and nine months ended September 28, 2012, respectively, reflecting its 50% ownership position. Subsequent to the sale of its investment in Apex, the Company has no continuing involvement in Apex's operations.

Discontinued_Operations

Discontinued Operations	9 Months Ended
	Sep. 27, 2013
Discontinued Operations and Disposal Groups [Abstract]
Discontinued Operations	DISCONTINUED OPERATIONS
	In the first quarter of 2012, the Company completed the sale of its Accu-Sort ("ASI") and Kollmorgen Electro-Optical ("KEO") businesses for an aggregate sale price of $337 million in cash. These businesses were part of the Industrial Technologies segment and had combined annual revenues of $275 million in 2011. The Company recorded an aggregate after-tax gain on the sale of these businesses of $93.7 million or $0.13 per diluted share in its first quarter 2012 results.
	The Company has reported the ASI and KEO businesses as discontinued operations in its consolidated financial statements. The results of operations prior to the businesses' sale in the first quarter of 2012 resulted in a loss from discontinued operations of $0.8 million. The Company allocated a portion of the consolidated interest expense to discontinued operations based on the ratio of the discontinued businesses’ net assets to the Company’s consolidated net assets.

Goodwill

Goodwill	9 Months Ended
	Sep. 27, 2013
Goodwill and Intangible Assets Disclosure [Abstract]
Goodwill	GOODWILL
	The following table shows the rollforward of goodwill reflected in the financial statements resulting from the Company’s activities during the nine months ended September 27, 2013 ($ in millions):
	Balance, December 31, 2012	$	15,462.00
	Attributable to 2013 acquisitions	554
	Foreign currency translation & other	8.4
	Balance, September 27, 2013	$	16,024.40
	The carrying value of goodwill by segment as of September 27, 2013 and December 31, 2012 is summarized as follows ($ in millions):
		September 27, 2013		December 31, 2012
	Test & Measurement	$	3,206.50	$	3,222.10
	Environmental	1,844.90		1,554.90
	Life Sciences & Diagnostics	6,321.50		6,138.90
	Dental	2,185.00		2,168.00
	Industrial Technologies	2,466.50		2,378.10
		$	16,024.40	$	15,462.00
	Goodwill arises from the purchase price for acquired businesses exceeding the fair value of tangible and intangible assets acquired less assumed liabilities and non-controlling interests. Management assesses the goodwill of each of its reporting units for impairment at least annually at the beginning of the fourth quarter and as “triggering” events occur that indicate that it is more likely than not that an impairment exists. The Company’s most recent annual impairment test was performed as of the first day of the Company’s fiscal fourth quarter of 2012 and no impairment was identified. There have been no "triggering" events which indicate a potential impairment in 2013. Reporting units resulting from recent acquisitions generally present the highest risk of impairment. Management believes the impairment risk associated with these reporting units typically decreases as such businesses are integrated into the Company and positioned for improved future earnings growth. In measuring the fair value of its reporting units, management relies on a number of factors including operating results, business plans, economic projections, anticipated future cash flows and transactions and market-place data. The factors used by management in its impairment analysis are inherently subject to uncertainty. While the Company believes it has made reasonable estimates and assumptions to calculate the fair value of its reporting units, if actual results are not consistent with management’s estimates and assumptions, goodwill may be overstated and a charge would need to be taken against net earnings.

Fair_Value_Measurements

Fair Value Measurements	9 Months Ended
	Sep. 27, 2013
Fair Value Disclosures [Abstract]
Fair Value Measurements	FAIR VALUE MEASUREMENTS
	Accounting standards define fair value based on an exit price model, establish a framework for measuring fair value where the Company’s assets and liabilities are required to be carried at fair value and provide for certain disclosures related to the valuation methods used within a valuation hierarchy as established within the accounting standards. This hierarchy prioritizes the inputs into three broad levels as follows. Level 1 inputs are quoted prices (unadjusted) in active markets for identical assets or liabilities. Level 2 inputs are quoted prices for similar assets and liabilities in active markets, quoted prices for identical or similar assets in markets that are not active, or other observable characteristics for the asset or liability, including interest rates, yield curves and credit risks, or inputs that are derived principally from or corroborated by observable market data through correlation. Level 3 inputs are unobservable inputs based on the Company’s assumptions. A financial asset or liability’s classification within the hierarchy is determined based on the lowest level input that is significant to the fair value measurement in its entirety.
	A summary of financial assets and liabilities that are measured at fair value on a recurring basis as of September 27, 2013 and December 31, 2012 were as follows ($ in millions):
		Quoted Prices		Significant Other		Significant		Total
		in Active		Observable Inputs		Unobservable
		Market		(Level 2)		Inputs
		(Level 1)				(Level 3)
	September 27, 2013:
	Assets:
	Available-for-sale securities	$	537.3	—		—		$	537.3
	Liabilities:
	Deferred compensation plans	—		$	67.9	—		67.9
	Currency swap agreement	—		3.4		—		3.4
	December 31, 2012:
	Assets:
	Available-for-sale securities	$	329.5	—		—		$	329.5
	Liabilities:
	Deferred compensation plans	—		$	64.5	—		64.5
	Currency swap agreement	—		24.9		—		24.9
	Available-for-sale securities are measured at fair value using quoted market prices in an active market and are included in other long-term assets in the accompanying Consolidated Condensed Balance Sheets.
	The Company has established nonqualified deferred compensation programs that permit officers, directors and certain management employees to defer a portion of their compensation, on a pre-tax basis, until their termination of employment (or board service, as applicable). All amounts deferred under such plans are unfunded, unsecured obligations of the Company and are presented as a component of the Company’s compensation and benefits accrual included in other long-term liabilities in the accompanying Consolidated Condensed Balance Sheets. Participants may choose among alternative earning rates for the amounts they defer, which are primarily based on investment options within the Company’s 401(k) program (except that the earnings rates for amounts deferred by the Company’s directors and amounts contributed unilaterally by the Company are entirely based on changes in the value of the Company’s common stock). Changes in the deferred compensation liability under these programs are recognized based on changes in the fair value of the participants’ accounts, which are based on the applicable earnings rates.
	In connection with a prior acquisition, the Company acquired a currency swap agreement that required the Company to purchase approximately 184 million Japanese Yen (JPY/¥) at a rate of $1/¥102.25 on a monthly basis through June 1, 2018. In January 2013, the Company terminated a portion of the currency swap agreement (¥6.0 billion of the ¥11.9 billion outstanding purchase commitment as of the termination date), reducing the Company's monthly purchase commitment to approximately ¥92 million. In connection with this partial termination of the currency swap agreement, the Company made a $10 million payment to the counterparty representing the fair value of the terminated portion of the currency swap. As of September 27, 2013, the aggregate Japanese Yen purchase commitment was approximately ¥5.1 billion (approximately $52 million based on exchange rates as of September 27, 2013). The currency swap does not qualify for hedge accounting, and as a result changes in the fair value of the currency swap are reflected in selling, general and administrative expenses in the accompanying Consolidated Condensed Statements of Earnings each reporting period. The fair value of this currency swap did not change significantly during the three months ended September 27, 2013. During the nine months ended September 27, 2013, the Company recorded pre-tax income of $11 million related to changes in the fair value of this currency swap. During the three and nine months ended September 28, 2012, the Company recorded a pre-tax charge of approximately $2 million and pre-tax income of approximately $6 million, respectively, related to changes in the fair value of this currency swap. The fair value of the currency swap is included in other long-term liabilities in the accompanying Consolidated Condensed Balance Sheets. Since there is not an active market for the currency swap, the Company obtains a market quote based on observable inputs, including foreign currency exchange market data, from the swap counterparties to adjust the currency swap to fair value each quarter.
	Fair Value of Financial Instruments
	In addition to the fair value disclosure requirements related to financial instruments carried at fair value, accounting standards require interim disclosures regarding the fair value of all of the Company’s financial instruments. The methods and significant assumptions used to estimate the fair value of financial instruments and any changes in methods or significant assumptions from prior periods are also required to be disclosed.
	The carrying amounts and fair values of financial instruments as of September 27, 2013 and December 31, 2012 were as follows ($ in millions):
		September 27, 2013				December 31, 2012
		Carrying		Fair Value		Carrying			Fair Value
		Amount				Amount
	Assets:
	Available-for-sale securities	$	537.3	$	537.3	$	329.5		$	329.5
	Liabilities:
	Short-term borrowings	56.5		56.5		55.5			55.5
	Long-term borrowings	3,445.50		3,901.10		5,287.60			5,917.30
	Currency swap agreement	3.4		3.4		24.9			24.9
	As of September 27, 2013 and December 31, 2012, available-for-sale securities and short and long-term borrowings were categorized as level 1, while the currency swap agreement was categorized as level 2. The fair values of available-for-sale securities and long-term borrowings were computed based on quoted market prices. The differences between the fair value and the carrying amounts of long-term borrowings (other than the Company’s Liquid Yield Option Notes due 2021 (the “LYONs”)) are attributable to changes in interest rates and/or the Company’s credit ratings subsequent to the incurrence of the borrowing. In the case of the LYONs, differences in the fair value from the carrying value are attributable to changes in the price of the Company’s common stock due to the LYONs' conversion features. The available-for-sale securities represent the Company’s investment in marketable securities that are accounted for at fair value. The currency swap agreement is accounted for at fair value based on a market quote obtained from the swap counterparties on a quarterly basis. The fair values of short-term borrowings, as well as, cash and cash equivalents, trade accounts receivable, net and trade accounts payable, approximate the carrying amounts due to the short-term maturities of these instruments.

Financing_Transactions

Financing Transactions	9 Months Ended
	Sep. 27, 2013
Debt Disclosure [Abstract]
Financing Transactions	FINANCING TRANSACTIONS
	As of September 27, 2013, the Company was in compliance with all of its debt covenants. The components of the Company’s debt as of September 27, 2013 and December 31, 2012 were as follows ($ in millions):
		September 27, 2013		December 31, 2012
	Commercial paper	$	450	$	1,224.50
	4.5% guaranteed Eurobond notes due 2013 (€500 million)	—		659.8
	Floating rate senior notes due 2013	—		300
	1.3% senior notes due 2014	400		400
	2.3% senior notes due 2016	500		500
	5.625% senior notes due 2018	500		500
	5.4% senior notes due 2019	750		750
	3.9% senior notes due 2021	600		600
	Zero-coupon LYONs due 2021	159.4		281.4
	Other	142.6		127.4
	Subtotal	3,502.00		5,343.10
	Less – current portion	56.5		55.5
	Long-term debt	$	3,445.50	$	5,287.60
	For a full description of the Company’s debt financing, reference is made to Note 10 of the Company’s financial statements as of and for the year ended December 31, 2012 included in the Company’s 2012 Annual Report on Form 10-K.
	During the nine months ended September 27, 2013, the Company repaid the €500 million principal amount of Eurobond notes due 2013 and the $300 million principal amount of floating rate senior notes due 2013 upon maturity in July and June 2013, respectively.
	During the nine months ended September 27, 2013, holders of certain of the Company’s LYONs converted such LYONs into an aggregate of approximately 4.4 million shares of the Company’s common stock, par value $0.01 per share. The Company’s deferred tax liability associated with the book and tax basis difference in the converted LYONs of approximately $41 million was transferred to additional paid-in capital as a result of the conversions.
	The Company satisfies any short-term liquidity needs that are not met through operating cash flow and available cash primarily through issuances of commercial paper under its U.S. and Euro commercial paper programs. As of September 27, 2013, borrowings outstanding under the Company’s U.S. commercial paper program had a weighted average annual interest rate of 0.1% and a weighted average remaining maturity of approximately twenty-two days. There was no commercial paper outstanding under the Euro commercial paper program as of September 27, 2013. As of September 27, 2013, the Company classified its borrowings outstanding under the commercial paper programs and its $400 million principal amount of 1.3% senior notes due June 23, 2014 as long-term debt in the accompanying Consolidated Condensed Balance Sheet as the Company has the intent and ability, as supported by availability under the Credit Facility referenced below, to refinance these borrowings for at least one year from the balance sheet date.
	Credit support for the commercial paper program is provided by a $2.5 billion unsecured multi-year revolving credit facility with a syndicate of banks that expires on July 15, 2016 (the “Credit Facility”). The Credit Facility can also be used for working capital and other general corporate purposes. As of September 27, 2013, no borrowings were outstanding under the Credit Facility and the Company was in compliance with all covenants under the facility. In addition to the Credit Facility, the Company has entered into reimbursement agreements with various commercial banks to support the issuance of letters of credit.

Defined_Benefit_Plans

Defined Benefit Plans	9 Months Ended
	Sep. 27, 2013
Defined Benefit Pension Plans and Defined Benefit Postretirement Plans Disclosure [Abstract]
Defined Benefit Plans	DEFINED BENEFIT PLANS
	The following sets forth the components of the Company’s net periodic benefit cost of the non-contributory defined benefit plans ($ in millions):
	U.S. Pension Benefits
		Three Months Ended						Nine Months Ended
		September 27, 2013			September 28, 2012			September 27, 2013			September 28, 2012
	Service cost	$	1.4		$	1.3		$	4.2		$	4.3
	Interest cost	25			26			72.4			75.8
	Expected return on plan assets	(31.2		)	(32.8		)	(94.0		)	(97.2		)
	Amortization of actuarial loss	8.6			12.7			22.6			31.7
	Net periodic benefit cost	$	3.8		$	7.2		$	5.2		$	14.6
	Non-U.S. Pension Benefits
		Three Months Ended						Nine Months Ended
		September 27, 2013			September 28, 2012			September 27, 2013			September 28, 2012
	Service cost	$	6.7		$	5.9		$	19.9		$	17.5
	Interest cost	10.4			10.7			31.2			32.2
	Expected return on plan assets	(8.4		)	(8.1		)	(25.5		)	(24.4		)
	Amortization of actuarial loss	1.9			1.1			5.9			3.4
	Amortization of prior service credit	(0.1		)	(0.1		)	(0.3		)	(0.3		)
	Settlement losses recognized	—			—			0.6			0.9
	Net periodic benefit cost	$	10.5		$	9.5		$	31.8		$	29.3
	The following sets forth the components of the Company’s net periodic benefit cost of the other post-retirement employee benefit plans ($ in millions):
		Three Months Ended						Nine Months Ended
		September 27, 2013			September 28, 2012			September 27, 2013			September 28, 2012
	Service cost	$	0.3		$	0.3		$	1.1		$	1.3
	Interest cost	2			2.4			6			7.8
	Amortization of prior service credit	(1.7		)	(1.4		)	(5.0		)	(4.2		)
	Amortization of actuarial loss	0.2			0.4			1			2.4
	Net periodic benefit cost	$	0.8		$	1.7		$	3.1		$	7.3
	Employer Contributions
	During 2013, the Company’s cash contribution requirements for its U.S. defined benefit pension plan are not expected to be significant. The Company’s cash contribution requirements for its non-U.S. defined benefit pension plans are expected to be approximately $52 million. The ultimate amounts to be contributed depend upon, among other things, legal requirements, underlying asset returns, the plan’s funded status, the anticipated tax deductibility of the contribution, local practices, market conditions, interest rates and other factors.

Stock_Transactions_And_StockBa

Stock Transactions And Stock-Based Compensation	9 Months Ended
	Sep. 27, 2013
Share-based Compensation [Abstract]
Stock-Based Compensation	STOCK TRANSACTIONS AND STOCK-BASED COMPENSATION
	In May 2012, the Company's shareholders approved an amendment to the Company's Restated Certificate of Incorporation to increase the number of authorized shares of common stock of the Company from 1.0 billion shares to 2.0 billion shares, $0.01 par value per share, which was filed and became effective on May 10, 2012.
	There were no repurchases of equity securities during the three or nine month periods ended September 27, 2013.  On July 16, 2013, the Company's Board of Directors approved a new stock repurchase program (the “2013 Repurchase Program”) authorizing the repurchase of up to 20 million shares of the Company's common stock from time to time on the open market or in privately negotiated transactions. The 2013 Repurchase Program replaces the repurchase program approved by the Company's Board of Directors in May 2010.  There is no expiration date for the 2013 Repurchase Program, and the timing and amount of any shares repurchased under the program will be determined by the Company's management based on its evaluation of market conditions and other factors.  The 2013 Repurchase Program may be suspended or discontinued at any time.  Any repurchased shares will be available for use in connection with the Company's equity compensation plans (or any successor plan) and for other corporate purposes. As of September 27, 2013, 20 million shares remained available for repurchase pursuant to the 2013 Repurchase Program.
	The Company accounts for stock-based compensation by measuring the cost of employee services received in exchange for all equity awards granted, including stock options, restricted stock units (“RSUs”) and restricted shares, based on the fair value of the award as of the grant date. The Company recognizes the compensation expense over the requisite service period (which is generally the vesting period but may be shorter than the vesting period if the employee becomes retirement eligible before the end of the vesting period). The fair value for RSU and restricted stock awards is calculated using the closing price of the Company’s common stock on the date of grant. The fair value of the options granted was calculated using a Black-Scholes Merton option pricing model (“Black-Scholes”).
	For a full description of the Company’s stock-based compensation, reference is made to Note 17 of the Company’s financial statements as of and for the year ended December 31, 2012 included in the Company’s 2012 Annual Report on Form 10-K. As of September 27, 2013, approximately 29 million shares of the Company’s common stock were reserved for issuance under the 2007 Stock Incentive Plan.
	The following summarizes the assumptions used in the Black-Scholes model to value options granted during the nine months ended September 27, 2013:
	Risk-free interest rate	0.98 – 2.33%
	Weighted average volatility	23.60%
	Dividend yield	0.20%
	Expected years until exercise	6.0 to 8.5
	The Black-Scholes model incorporates assumptions to value stock-based awards. The risk-free rate of interest for periods within the contractual life of the option is based on a zero-coupon U.S. government instrument whose maturity period equals or approximates the option’s expected term. Expected volatility is based on implied volatility from traded options on the Company’s stock and historical volatility of the Company’s stock. The dividend yield is calculated by dividing the Company’s annual dividend, based on the most recent quarterly dividend rate, by the closing stock price on the grant date. To estimate the option exercise timing to be used in the valuation model, in addition to considering the vesting period and contractual term of the option, the Company analyzes and considers actual historical exercise data for previously granted options. The Company stratifies its employee population into multiple groups for option valuation and attribution purposes based upon distinctive patterns of forfeiture rates and option holding periods.
	The amount of stock-based compensation expense recognized during a period is also based on the portion of the awards that are ultimately expected to vest. The Company estimates pre-vesting forfeitures at the time of grant by analyzing historical data and revises those estimates in subsequent periods if actual forfeitures differ from those estimates. Ultimately, the total expense recognized over the vesting period will equal the fair value of awards that actually vest.
	The following table summarizes the components of the Company’s stock-based compensation program recorded as expense ($ in millions):
		Three Months Ended								Nine Months Ended
		September 27, 2013				September 28, 2012				September 27, 2013			September 28, 2012
	RSUs and restricted shares:
	Pre-tax compensation expense	$	17.6			$	16			$	49.9		$	43.2
	Income tax benefit	(5.2		)		(4.9		)		(15.0		)	(14.1		)
	RSU and restricted share expense, net of income taxes	$	12.4			$	11.1			$	34.9		$	29.1
	Stock options:
	Pre-tax compensation expense	$	12			$	13			$	35.8		$	36.2
	Income tax benefit	(3.7		)		(4.0		)		(11.0		)	(11.0		)
	Stock option expense, net of income taxes	$	8.3			$	9			$	24.8		$	25.2
	Total stock-based compensation:
	Pre-tax compensation expense	$	29.6			$	29			$	85.7		$	79.4
	Income tax benefit	(8.9		)		(8.9		)		(26.0		)	(25.1		)
	Total stock-based compensation expense, net of income taxes	$	20.7			$	20.1			$	59.7		$	54.3
	Stock-based compensation has been recognized as a component of selling, general and administrative expenses in the accompanying Consolidated Condensed Statements of Earnings. As of September 27, 2013, $162 million of total unrecognized compensation cost related to RSUs is expected to be recognized over a weighted average period of approximately three years. As of September 27, 2013, $145 million of total unrecognized compensation cost related to stock options is expected to be recognized over a weighted average period of approximately three years. Both amounts will be adjusted for any future changes in estimated forfeitures.
	Option activity under the Company’s stock plans as of September 27, 2013 and changes during the nine months then ended were as follows (in thousands, except exercise price and number of years):
		Options			Weighted				Weighted Average		Aggregate
					Average				Remaining		Intrinsic
					Exercise				Contractual Term		Value
					Price				(in Years)
	Outstanding as of December 31, 2012	27,372			$	37.94
	Granted	3,609			64.43
	Exercised	(4,317	)		31.12
	Cancelled/forfeited	(866	)		44.41
	Outstanding as of September 27, 2013	25,798			$	42.57			6		$	704,366
	Vested and Expected to Vest as of September 27, 2013 (1)	25,028			$	42.15			6		$	693,732
	Vested as of September 27, 2013	13,732			$	34.99			4		$	479,041
	-1	The “Expected to Vest” options are the net unvested options that remain after applying the pre-vesting forfeiture rate assumption to total unvested options.
	The aggregate intrinsic value in the table above represents the total pre-tax intrinsic value (the difference between the Company’s closing stock price on the last trading day of the third quarter of 2013 and the exercise price, multiplied by the number of in-the-money options) that would have been received by the option holders had all option holders exercised their options on September 27, 2013. The amount of aggregate intrinsic value will change based on the price of the Company’s common stock.
	The aggregate intrinsic value of options exercised during the nine months ended September 27, 2013 and September 28, 2012 was $136 million and $161 million, respectively. Exercise of options during the first nine months of 2013 and 2012 resulted in cash receipts of $134 million and $146 million, respectively. The Company realized a tax benefit of approximately $12 million and $43 million in the three and nine months ended September 27, 2013 related to the exercise of employee stock options. The net income tax benefit in excess of the expense recorded for financial reporting purposes (the “excess tax benefit”) has been recorded as an increase to additional paid-in capital and is reflected as a financing cash inflow in the accompanying Consolidated Condensed Statements of Cash Flows.
	The following table summarizes information on unvested RSUs and restricted shares activity during the nine months ended September 27, 2013:
		Number of RSUs/Restricted			Weighted Average
		Shares (in thousands)			Grant-Date  Fair Value
	Unvested as of December 31, 2012	5,585			$	43.29
	Granted	1,531			64.54
	Vested	(1,332	)		37.63
	Forfeited	(450	)		44.86
	Unvested as of September 27, 2013	5,334			$	50.67
	The Company realized a tax benefit of approximately $12 million and $26 million in the three and nine months ended September 27, 2013, respectively, related to the vesting of RSUs. The excess tax benefit attributable to RSUs and restricted stock have been recorded as an increase to additional paid-in capital and is reflected as a financing cash inflow in the accompanying Consolidated Condensed Statements of Cash Flows.
	In connection with the exercise of certain stock options and the vesting of RSUs and restricted shares previously issued by the Company, a number of shares sufficient to fund statutory minimum tax withholding requirements has been withheld from the total shares issued or released to the award holder (though under the terms of the applicable plan, the shares are considered to have been issued and are not added back to the pool of shares available for grant). During the first nine months of 2013, approximately 496 thousand shares with an aggregate value of $32 million were withheld to satisfy the requirement. The withholding is treated as a reduction in additional paid-in capital in the accompanying Consolidated Condensed Statement of Stockholders’ Equity.

Restructuring_And_Other_Relate

Restructuring And Other Related Charges	9 Months Ended
	Sep. 27, 2013
Restructuring Charges [Abstract]
Restructuring And Other Related Charges	RESTRUCTURING AND OTHER RELATED CHARGES
	During 2012, the Company recorded pre-tax restructuring and other related charges totaling $123 million. These costs were incurred to position the Company to provide superior products and services to its customers in a cost efficient manner, and in light of the uncertainties in the macro-economic environment. For a full description of the Company’s restructuring activities, reference is made to Note 14 of the Company’s financial statements as of and for the year ended December 31, 2012 included in the Company’s 2012 Annual Report on Form 10-K.
	Substantially all restructuring activities initiated in 2012 were completed by December 31, 2012. The Company expects substantially all cash payments associated with remaining termination benefits will be paid during 2013. The table below summarizes the accrual balance and utilization by type of restructuring cost associated with the 2012 actions ($ in millions):
		Balance as of		Paid/			Balance as of
		December 31, 2012		Settled			September 27, 2013
	Restructuring charges:
	Employee severance and related	$	96.9	$	(72.2	)	$	24.7
	Facility exit and related	6.8		(5.1		)	1.7
	Total restructuring	$	103.7	$	(77.3	)	$	26.4

Contingencies

Contingencies	9 Months Ended
	Sep. 27, 2013
Commitments and Contingencies Disclosure [Abstract]
Contingencies	CONTINGENCIES
	For a description of the Company’s litigation and contingencies, reference is made to Note 16 of the Company’s financial statements as of and for the year ended December 31, 2012 included in the Company’s 2012 Annual Report on Form 10-K.
	The Company generally accrues estimated warranty costs at the time of sale. In general, manufactured products are warranted against defects in material and workmanship when properly used for their intended purpose, installed correctly and appropriately maintained. Warranty period terms depend on the nature of the product and range from ninety days up to the life of the product. The amount of the accrued warranty liability is determined based on historical information such as past experience, product failure rates or number of units repaired, estimated cost of material and labor, and in certain instances estimated property damage. The accrued warranty liability is reviewed on a quarterly basis and may be adjusted as additional information regarding expected warranty costs becomes known.
	In certain cases, the Company will sell extended warranty or maintenance agreements. The proceeds from these agreements are deferred and recognized as revenue over the term of the agreement.
	The following is a rollforward of the Company’s accrued warranty liability for the nine months ended September 27, 2013 ($ in millions):
	Balance, December 31, 2012	$	140.7
	Accruals for warranties issued during the period	109.6
	Settlements made	(106.9		)
	Additions due to acquisitions	2.6
	Effect of foreign currency translation	(0.4		)
	Balance, September 27, 2013	$	145.6

Net_Earnings_Per_Share_From_Co

Net Earnings Per Share From Continuing Operations	9 Months Ended
	Sep. 27, 2013
Earnings Per Share [Abstract]
Net Earnings Per Share From Continuing Operations	NET EARNINGS PER SHARE FROM CONTINUING OPERATIONS
	Basic net earnings per share (“EPS”) from continuing operations is calculated by dividing net earnings from continuing operations by the weighted average number of common shares outstanding for the applicable period. Diluted net EPS from continuing operations is computed based on the weighted average number of common shares outstanding increased by the number of additional shares that would have been outstanding had the potentially dilutive common shares been issued and reduced by the number of shares the Company could have repurchased with the proceeds from the issuance of the potentially dilutive shares. There were no anti-dilutive options for the three months ended September 27, 2013. For the nine months ended September 27, 2013, approximately 1 million options to purchase shares were not included in the diluted earnings per share calculation as the impact of their inclusion would have been anti-dilutive. For the three and nine months ended September 28, 2012, approximately 2 million options to purchase shares were not included in the diluted earnings per share calculation as the impact of their inclusion would have been anti-dilutive.
	Information related to the calculation of net earnings from continuing operations per share of common stock is summarized as follows ($ and shares in millions, except per share amounts):
		Net Earnings		Shares	Per Share
		From Continuing		(Denominator)	Amount
		Operations
		(Numerator)
	For the Three Months Ended September 27, 2013:
	Basic EPS	$	597	697.7	$	0.86
	Adjustment for interest on convertible debentures	0.6		—
	Incremental shares from assumed exercise of dilutive options and vesting of dilutive RSUs	—		8.6
	Incremental shares from assumed conversion of the convertible debentures	—		5.6
	Diluted EPS	$	597.6	711.9	$	0.84
	For the Three Months Ended September 28, 2012:
	Basic EPS	$	548.7	695.2	$	0.79
	Adjustment for interest on convertible debentures	1.4		—
	Incremental shares from assumed exercise of dilutive options and vesting of dilutive RSUs	—		8.4
	Incremental shares from assumed conversion of the convertible debentures	—		10.3
	Diluted EPS	$	550.1	713.9	$	0.77
	For the Nine Months Ended September 27, 2013:
	Basic EPS	$	1,905.70	695	$	2.74
	Adjustment for interest on convertible debentures	2.6		—
	Incremental shares from assumed exercise of dilutive options and vesting of dilutive RSUs	—		8.5
	Incremental shares from assumed conversion of the convertible debentures	—		6.6
	Diluted EPS	$	1,908.30	710.1	$	2.69
	For the Nine Months Ended September 28, 2012:
	Basic EPS	$	1,668.90	694.1	$	2.4
	Adjustment for interest on convertible debentures	4.4		—
	Incremental shares from assumed exercise of dilutive options and vesting of dilutive RSUs	—		9.9
	Incremental shares from assumed conversion of the convertible debentures	—		10.3
	Diluted EPS	$	1,673.30	714.3	$	2.34

Segment_Information

Segment Information	9 Months Ended
	Sep. 27, 2013
Segment Reporting, Measurement Disclosures [Abstract]
Segment Information	SEGMENT INFORMATION
	The Company operates and reports its results in five separate business segments consisting of the Test & Measurement, Environmental, Life Sciences & Diagnostics, Dental and Industrial Technologies segments. The Company’s equity in earnings of the Apex joint venture is shown separately in the Company’s segment disclosures. There has been no material change in total assets or liabilities by segment since December 31, 2012, except for the sale of the investment in the Apex joint venture in February 2013. Segment results are shown below ($ in millions):
		Three Months Ended						Nine Months Ended
		September 27, 2013			September 28, 2012			September 27, 2013			September 28, 2012
	Sales:
	Test & Measurement	$	808.6		$	814.5		$	2,519.00		$	2,517.30
	Environmental	828.7			754.4			2,380.80			2,212.90
	Life Sciences & Diagnostics	1,675.10			1,518.10			4,916.80			4,647.40
	Dental	510.2			488.9			1,504.70			1,452.40
	Industrial Technologies	846.5			839.6			2,530.00			2,455.20
		$	4,669.10		$	4,415.50		$	13,851.30		$	13,285.20
	Operating Profit:
	Test & Measurement	$	155		$	163.6		$	520.7		$	539.4
	Environmental	171.6			162.4			485.6			456.6
	Life Sciences & Diagnostics	246.8			185.6			686.8			599.4
	Dental	82.2			76			223.9			206.5
	Industrial Technologies	191.7			183.5			566.7			531.6
	Equity method earnings of Apex joint venture	—			18.5			—			50.9
	Other	(34.9		)	(33.8		)	(96.8		)	(82.4		)
		$	812.4		$	755.8		$	2,386.90		$	2,302.00

General_Tables

General (Tables)	9 Months Ended
	Sep. 27, 2013
Organization, Consolidation and Presentation of Financial Statements [Abstract]
Components Of Accumulated Other Comprehensive Income	The changes in accumulated other comprehensive income (loss) by component for the three and nine months ended September 27, 2013 and September 28, 2012 are summarized below ($ in millions).
		Foreign			Pension and post-retirement plan benefit adjustments				Unrealized			Total
		currency							gain on
		translation							available-for-
		adjustments							sale securities
	For the Three Months Ended September 27, 2013:
	Balance, June 28, 2013	$	89.7		$	(644.7	)		$	176.4		$	(378.6	)
	Other comprehensive income (loss) before reclassifications:
	Pre-tax income	288.2			—				95.4			383.6
	Income tax expense	—			—				(35.7		)	(35.7		)
	Other comprehensive income (loss) before reclassifications, net of income taxes	288.2			—				59.7			347.9
	Amounts reclassified from accumulated other comprehensive income (loss):
	Pre-tax income	—			8.4			-1	—			8.4
	Income tax expense	—			(2.9		)		—			(2.9		)
	Amounts reclassified from accumulated other comprehensive income (loss), net of income taxes	—			5.5				—			5.5
	Net current period other comprehensive income, net of income taxes	288.2			5.5				59.7			353.4
	Balance, September 27, 2013	$	377.9		$	(639.2	)		$	236.1		$	(25.2	)
	(1) This accumulated other comprehensive income (loss) component is included in the computation of net periodic pension cost (refer to Note 8 for additional details).
		Foreign			Pension and post-retirement plan benefit adjustments				Unrealized			Total
		currency							gain on
		translation							available-for-
		adjustments							sale securities
	For the Three Months Ended September 28, 2012:
	Balance, June 29, 2012	$	284.4		$	(503.1	)		$	143.8		$	(74.9	)
	Net current period other comprehensive income (loss):
	Pre-tax income	193.5			12.7				37.2			243.4
	Income tax expense	—			(4.6		)		(14.0		)	(18.6		)
	Net current period other comprehensive income, net of income taxes	193.5			8.1				23.2			224.8
	Balance, September 28, 2012	$	477.9		$	(495.0	)		$	167		$	149.9
	For the Nine Months Ended September 27, 2013:
	Balance, December 31, 2012	$	475.3		$	(655.7	)		$	121.2		$	(59.2	)
	Other comprehensive income (loss) before reclassifications:
	Pre-tax income (loss)	(97.4		)	—				183.8			86.4
	Income tax expense	—			—				(68.9		)	(68.9		)
	Other comprehensive income (loss) before reclassifications, net of income taxes	(97.4		)	—				114.9			17.5
	Amounts reclassified from accumulated other comprehensive income (loss):
	Pre-tax income	—			25.2			-1	—			25.2
	Income tax expense	—			(8.7		)		—			(8.7		)
	Amounts reclassified from accumulated other comprehensive income (loss), net of income taxes	—			16.5				—			16.5
	Net current period other comprehensive income (loss), net of income taxes	(97.4		)	16.5				114.9			34
	Balance, September 27, 2013	$	377.9		$	(639.2	)		$	236.1		$	(25.2	)
	For the Nine Months Ended September 28, 2012:
	Balance, December 31, 2011	$	384.5		$	(516.0	)		$	94.6		$	(36.9	)
	Net current period other comprehensive income (loss):
	Pre-tax income	93.4			33				115.9			242.3
	Income tax expense	—			(12.0		)		(43.5		)	(55.5		)
	Net current period other comprehensive income, net of income taxes	93.4			21				72.4			186.8
	Balance, September 28, 2012	$	477.9		$	(495.0	)		$	167		$	149.9
	(1) This accumulated other comprehensive income (loss) component is included in the computation of net periodic pension cost (refer to Note 8 for additional details).

Acquisitions_Tables

Acquisitions (Tables)	9 Months Ended
	Sep. 27, 2013
Business Combinations [Abstract]
Schedule of Purchase Price Allocation	The following table summarizes the estimated fair values of the assets acquired and liabilities assumed at the date of acquisition for all acquisitions consummated during the nine months ended September 27, 2013 ($ in millions):
	Trade accounts receivable	$	78.1
	Inventories	22.5
	Property, plant and equipment	47.5
	Goodwill	554
	Other intangible assets, primarily trade names, customer relationships and patents	343.4
	Trade accounts payable	(24.9		)
	Other assets and liabilities, net	(130.5		)
	Assumed debt	(21.2		)
	Non-controlling interest acquired	(0.3		)
	Net cash consideration	$	868.6
Results Of Operations If Acquisition Was Consummated	The pro forma information is presented for informational purposes only and is not necessarily indicative of the results of operations that actually would have been achieved had the acquisitions been consummated as of that time ($ in millions, except per share amounts):
		Three Months Ended					Nine Months Ended
		September 27, 2013			September 28, 2012		September 27, 2013		September 28, 2012
	Sales	$	4,679.90		$	4,558.90	$	13,978.60	$	13,771.90
	Net earnings from continuing operations	596.5			551.3		1,907.50		1,685.10
	Diluted net earnings per share from continuing operations	$	0.84		$	0.77	$	2.69	$	2.37

Sale_of_Joint_Venture_Tables

Sale of Joint Venture (Tables)	9 Months Ended
	Sep. 27, 2013
Equity Method Investments and Joint Ventures [Abstract]
Schedule of Sale of Equity Method Investee Disclosure	The gain is computed as the difference between the book value of the Company's investment in Apex at the time of sale and the fair value of the consideration received in exchange, as indicated in the table below ($ in millions):
	Fair value of consideration received:
	Cash, including $66.6 of dividends received during 2013 prior to the closing of the sale	$	758.6
	Note receivable	38.5
	Total fair value of consideration received	797.1
	Less book value of investment in unconsolidated joint venture	545.6
	Less other related costs and expenses	21.7
	Pre-tax gain on sale of unconsolidated joint venture	229.8
	Income tax expense	86.2
	After-tax gain on sale of unconsolidated joint venture	$	143.6

Goodwill_Tables

Goodwill (Tables)	9 Months Ended
	Sep. 27, 2013
Goodwill and Intangible Assets Disclosure [Abstract]
Rollforward Of Goodwill	The following table shows the rollforward of goodwill reflected in the financial statements resulting from the Company’s activities during the nine months ended September 27, 2013 ($ in millions):
	Balance, December 31, 2012	$	15,462.00
	Attributable to 2013 acquisitions	554
	Foreign currency translation & other	8.4
	Balance, September 27, 2013	$	16,024.40
	The carrying value of goodwill by segment as of September 27, 2013 and December 31, 2012 is summarized as follows ($ in millions):
		September 27, 2013		December 31, 2012
	Test & Measurement	$	3,206.50	$	3,222.10
	Environmental	1,844.90		1,554.90
	Life Sciences & Diagnostics	6,321.50		6,138.90
	Dental	2,185.00		2,168.00
	Industrial Technologies	2,466.50		2,378.10
		$	16,024.40	$	15,462.00

Fair_Value_Measurements_Tables

Fair Value Measurements (Tables)	9 Months Ended
	Sep. 27, 2013
Fair Value, Assets and Liabilities Measured on Recurring Basis [Abstract]
Financial Assets And Liabilities Carried At Fair Value	A summary of financial assets and liabilities that are measured at fair value on a recurring basis as of September 27, 2013 and December 31, 2012 were as follows ($ in millions):
		Quoted Prices		Significant Other		Significant		Total
		in Active		Observable Inputs		Unobservable
		Market		(Level 2)		Inputs
		(Level 1)				(Level 3)
	September 27, 2013:
	Assets:
	Available-for-sale securities	$	537.3	—		—		$	537.3
	Liabilities:
	Deferred compensation plans	—		$	67.9	—		67.9
	Currency swap agreement	—		3.4		—		3.4
	December 31, 2012:
	Assets:
	Available-for-sale securities	$	329.5	—		—		$	329.5
	Liabilities:
	Deferred compensation plans	—		$	64.5	—		64.5
	Currency swap agreement	—		24.9		—		24.9
Carrying Amounts And Fair Values Of Financial Instruments	The carrying amounts and fair values of financial instruments as of September 27, 2013 and December 31, 2012 were as follows ($ in millions):
		September 27, 2013				December 31, 2012
		Carrying		Fair Value		Carrying			Fair Value
		Amount				Amount
	Assets:
	Available-for-sale securities	$	537.3	$	537.3	$	329.5		$	329.5
	Liabilities:
	Short-term borrowings	56.5		56.5		55.5			55.5
	Long-term borrowings	3,445.50		3,901.10		5,287.60			5,917.30
	Currency swap agreement	3.4		3.4		24.9			24.9

Financing_Transactions_Tables

Financing Transactions (Tables)	9 Months Ended
	Sep. 27, 2013
Debt Disclosure [Abstract]
Components Of Debt	The components of the Company’s debt as of September 27, 2013 and December 31, 2012 were as follows ($ in millions):
		September 27, 2013		December 31, 2012
	Commercial paper	$	450	$	1,224.50
	4.5% guaranteed Eurobond notes due 2013 (€500 million)	—		659.8
	Floating rate senior notes due 2013	—		300
	1.3% senior notes due 2014	400		400
	2.3% senior notes due 2016	500		500
	5.625% senior notes due 2018	500		500
	5.4% senior notes due 2019	750		750
	3.9% senior notes due 2021	600		600
	Zero-coupon LYONs due 2021	159.4		281.4
	Other	142.6		127.4
	Subtotal	3,502.00		5,343.10
	Less – current portion	56.5		55.5
	Long-term debt	$	3,445.50	$	5,287.60

Defined_Benefit_Plans_Tables

Defined Benefit Plans (Tables)	9 Months Ended
	Sep. 27, 2013
Defined Benefit Plans
Defined Benefit Plan Disclosure [Line Items]
Components Of Net Periodic Benefit Cost	The following sets forth the components of the Company’s net periodic benefit cost of the non-contributory defined benefit plans ($ in millions):
	U.S. Pension Benefits
		Three Months Ended						Nine Months Ended
		September 27, 2013			September 28, 2012			September 27, 2013			September 28, 2012
	Service cost	$	1.4		$	1.3		$	4.2		$	4.3
	Interest cost	25			26			72.4			75.8
	Expected return on plan assets	(31.2		)	(32.8		)	(94.0		)	(97.2		)
	Amortization of actuarial loss	8.6			12.7			22.6			31.7
	Net periodic benefit cost	$	3.8		$	7.2		$	5.2		$	14.6
	Non-U.S. Pension Benefits
		Three Months Ended						Nine Months Ended
		September 27, 2013			September 28, 2012			September 27, 2013			September 28, 2012
	Service cost	$	6.7		$	5.9		$	19.9		$	17.5
	Interest cost	10.4			10.7			31.2			32.2
	Expected return on plan assets	(8.4		)	(8.1		)	(25.5		)	(24.4		)
	Amortization of actuarial loss	1.9			1.1			5.9			3.4
	Amortization of prior service credit	(0.1		)	(0.1		)	(0.3		)	(0.3		)
	Settlement losses recognized	—			—			0.6			0.9
	Net periodic benefit cost	$	10.5		$	9.5		$	31.8		$	29.3
Other Post-Retirement Benefits
Defined Benefit Plan Disclosure [Line Items]
Components Of Net Periodic Benefit Cost	The following sets forth the components of the Company’s net periodic benefit cost of the other post-retirement employee benefit plans ($ in millions):
		Three Months Ended						Nine Months Ended
		September 27, 2013			September 28, 2012			September 27, 2013			September 28, 2012
	Service cost	$	0.3		$	0.3		$	1.1		$	1.3
	Interest cost	2			2.4			6			7.8
	Amortization of prior service credit	(1.7		)	(1.4		)	(5.0		)	(4.2		)
	Amortization of actuarial loss	0.2			0.4			1			2.4
	Net periodic benefit cost	$	0.8		$	1.7		$	3.1		$	7.3

Stock_Transactions_And_StockBa1

Stock Transactions And Stock-Based Compensation (Tables)	9 Months Ended
	Sep. 27, 2013
Share-based Compensation [Abstract]
Assumptions Used In The Black-Scholes Model To Value Options Granted	The following summarizes the assumptions used in the Black-Scholes model to value options granted during the nine months ended September 27, 2013:
	Risk-free interest rate	0.98 – 2.33%
	Weighted average volatility	23.60%
	Dividend yield	0.20%
	Expected years until exercise	6.0 to 8.5
Components Of Stock-Based Compensation Program	The following table summarizes the components of the Company’s stock-based compensation program recorded as expense ($ in millions):
		Three Months Ended								Nine Months Ended
		September 27, 2013				September 28, 2012				September 27, 2013			September 28, 2012
	RSUs and restricted shares:
	Pre-tax compensation expense	$	17.6			$	16			$	49.9		$	43.2
	Income tax benefit	(5.2		)		(4.9		)		(15.0		)	(14.1		)
	RSU and restricted share expense, net of income taxes	$	12.4			$	11.1			$	34.9		$	29.1
	Stock options:
	Pre-tax compensation expense	$	12			$	13			$	35.8		$	36.2
	Income tax benefit	(3.7		)		(4.0		)		(11.0		)	(11.0		)
	Stock option expense, net of income taxes	$	8.3			$	9			$	24.8		$	25.2
	Total stock-based compensation:
	Pre-tax compensation expense	$	29.6			$	29			$	85.7		$	79.4
	Income tax benefit	(8.9		)		(8.9		)		(26.0		)	(25.1		)
	Total stock-based compensation expense, net of income taxes	$	20.7			$	20.1			$	59.7		$	54.3
Option Activity Under The Company's Stock Plans	Option activity under the Company’s stock plans as of September 27, 2013 and changes during the nine months then ended were as follows (in thousands, except exercise price and number of years):
		Options			Weighted				Weighted Average		Aggregate
					Average				Remaining		Intrinsic
					Exercise				Contractual Term		Value
					Price				(in Years)
	Outstanding as of December 31, 2012	27,372			$	37.94
	Granted	3,609			64.43
	Exercised	(4,317	)		31.12
	Cancelled/forfeited	(866	)		44.41
	Outstanding as of September 27, 2013	25,798			$	42.57			6		$	704,366
	Vested and Expected to Vest as of September 27, 2013 (1)	25,028			$	42.15			6		$	693,732
	Vested as of September 27, 2013	13,732			$	34.99			4		$	479,041
	-1	The “Expected to Vest” options are the net unvested options that remain after applying the pre-vesting forfeiture rate assumption to total unvested options.
RSU And Restricted Shares Activity	The following table summarizes information on unvested RSUs and restricted shares activity during the nine months ended September 27, 2013:
		Number of RSUs/Restricted			Weighted Average
		Shares (in thousands)			Grant-Date  Fair Value
	Unvested as of December 31, 2012	5,585			$	43.29
	Granted	1,531			64.54
	Vested	(1,332	)		37.63
	Forfeited	(450	)		44.86
	Unvested as of September 27, 2013	5,334			$	50.67

Restructuring_And_Other_Relate1

Restructuring And Other Related Charges (Tables)	9 Months Ended
	Sep. 27, 2013
Restructuring Charges [Abstract]
Accrual Balance And Utilization Of Restructuring Cost	The table below summarizes the accrual balance and utilization by type of restructuring cost associated with the 2012 actions ($ in millions):
		Balance as of		Paid/			Balance as of
		December 31, 2012		Settled			September 27, 2013
	Restructuring charges:
	Employee severance and related	$	96.9	$	(72.2	)	$	24.7
	Facility exit and related	6.8		(5.1		)	1.7
	Total restructuring	$	103.7	$	(77.3	)	$	26.4

Contingencies_Tables

Contingencies (Tables)	9 Months Ended
	Sep. 27, 2013
Commitments and Contingencies Disclosure [Abstract]
Warranty Accrual	The following is a rollforward of the Company’s accrued warranty liability for the nine months ended September 27, 2013 ($ in millions):
	Balance, December 31, 2012	$	140.7
	Accruals for warranties issued during the period	109.6
	Settlements made	(106.9		)
	Additions due to acquisitions	2.6
	Effect of foreign currency translation	(0.4		)
	Balance, September 27, 2013	$	145.6

Net_Earnings_Per_Share_From_Co1

Net Earnings Per Share From Continuing Operations (Tables)	9 Months Ended
	Sep. 27, 2013
Earnings Per Share [Abstract]
Components Of Basic And Diluted Earnings Per Share	Information related to the calculation of net earnings from continuing operations per share of common stock is summarized as follows ($ and shares in millions, except per share amounts):
		Net Earnings		Shares	Per Share
		From Continuing		(Denominator)	Amount
		Operations
		(Numerator)
	For the Three Months Ended September 27, 2013:
	Basic EPS	$	597	697.7	$	0.86
	Adjustment for interest on convertible debentures	0.6		—
	Incremental shares from assumed exercise of dilutive options and vesting of dilutive RSUs	—		8.6
	Incremental shares from assumed conversion of the convertible debentures	—		5.6
	Diluted EPS	$	597.6	711.9	$	0.84
	For the Three Months Ended September 28, 2012:
	Basic EPS	$	548.7	695.2	$	0.79
	Adjustment for interest on convertible debentures	1.4		—
	Incremental shares from assumed exercise of dilutive options and vesting of dilutive RSUs	—		8.4
	Incremental shares from assumed conversion of the convertible debentures	—		10.3
	Diluted EPS	$	550.1	713.9	$	0.77
	For the Nine Months Ended September 27, 2013:
	Basic EPS	$	1,905.70	695	$	2.74
	Adjustment for interest on convertible debentures	2.6		—
	Incremental shares from assumed exercise of dilutive options and vesting of dilutive RSUs	—		8.5
	Incremental shares from assumed conversion of the convertible debentures	—		6.6
	Diluted EPS	$	1,908.30	710.1	$	2.69
	For the Nine Months Ended September 28, 2012:
	Basic EPS	$	1,668.90	694.1	$	2.4
	Adjustment for interest on convertible debentures	4.4		—
	Incremental shares from assumed exercise of dilutive options and vesting of dilutive RSUs	—		9.9
	Incremental shares from assumed conversion of the convertible debentures	—		10.3
	Diluted EPS	$	1,673.30	714.3	$	2.34

Segment_Information_Tables

Segment Information (Tables)	9 Months Ended
	Sep. 27, 2013
Segment Reporting, Measurement Disclosures [Abstract]
Segment Results	Segment results are shown below ($ in millions):
		Three Months Ended						Nine Months Ended
		September 27, 2013			September 28, 2012			September 27, 2013			September 28, 2012
	Sales:
	Test & Measurement	$	808.6		$	814.5		$	2,519.00		$	2,517.30
	Environmental	828.7			754.4			2,380.80			2,212.90
	Life Sciences & Diagnostics	1,675.10			1,518.10			4,916.80			4,647.40
	Dental	510.2			488.9			1,504.70			1,452.40
	Industrial Technologies	846.5			839.6			2,530.00			2,455.20
		$	4,669.10		$	4,415.50		$	13,851.30		$	13,285.20
	Operating Profit:
	Test & Measurement	$	155		$	163.6		$	520.7		$	539.4
	Environmental	171.6			162.4			485.6			456.6
	Life Sciences & Diagnostics	246.8			185.6			686.8			599.4
	Dental	82.2			76			223.9			206.5
	Industrial Technologies	191.7			183.5			566.7			531.6
	Equity method earnings of Apex joint venture	—			18.5			—			50.9
	Other	(34.9		)	(33.8		)	(96.8		)	(82.4		)
		$	812.4		$	755.8		$	2,386.90		$	2,302.00

General_General_Components_of_

General General (Components of Accumulated Other Comprehensive Income) (Details) (USD $)	3 Months Ended		9 Months Ended
In Millions, unless otherwise specified	Sep. 27, 2013	Sep. 28, 2012	Sep. 27, 2013	Sep. 28, 2012
Accumulated Other Comprehensive Income Loss Total [Roll Forward]
Beginning balance	($378.60)	($74.90)	($59.20)	($36.90)
Pre-tax income		243.4		242.3
Income tax expense		-18.6		-55.5
Other comprehensive income, net of income taxes	353.4	224.8	34	186.8
Ending balance	-25.2	149.9	-25.2	149.9
Reclassification out of Accumulated Other Comprehensive Income [Member]
Accumulated Other Comprehensive Income Loss Total [Roll Forward]
Pre-tax income	8.4		25.2
Income tax expense	-2.9		-8.7
Other comprehensive income, net of income taxes	5.5		16.5
Other Comprehensive Income (Loss) Before Reclassifications [Member]
Accumulated Other Comprehensive Income Loss Total [Roll Forward]
Pre-tax income	383.6		86.4
Income tax expense	-35.7		-68.9
Other comprehensive income, net of income taxes	347.9		17.5
Foreign currency translation adjustments [Member]
Accumulated Other Comprehensive Income Loss Total [Roll Forward]
Beginning balance	89.7	284.4	475.3	384.5
Pre-tax income		193.5		93.4
Income tax expense		0		0
Other comprehensive income, net of income taxes	288.2	193.5	-97.4	93.4
Ending balance	377.9	477.9	377.9	477.9
Foreign currency translation adjustments [Member] | Reclassification out of Accumulated Other Comprehensive Income [Member]
Accumulated Other Comprehensive Income Loss Total [Roll Forward]
Pre-tax income	0		0
Income tax expense	0		0
Other comprehensive income, net of income taxes	0		0
Foreign currency translation adjustments [Member] | Other Comprehensive Income (Loss) Before Reclassifications [Member]
Accumulated Other Comprehensive Income Loss Total [Roll Forward]
Pre-tax income	288.2		-97.4
Income tax expense	0		0
Other comprehensive income, net of income taxes	288.2		-97.4
Pension and Post-Retirement Plan Benefit [Member]
Accumulated Other Comprehensive Income Loss Total [Roll Forward]
Beginning balance	-644.7	-503.1	-655.7	-516
Pre-tax income		12.7		33
Income tax expense		-4.6		-12
Other comprehensive income, net of income taxes	5.5	8.1	16.5	21
Ending balance	-639.2	-495	-639.2	-495
Pension and Post-Retirement Plan Benefit [Member] | Reclassification out of Accumulated Other Comprehensive Income [Member]
Accumulated Other Comprehensive Income Loss Total [Roll Forward]
Pre-tax income	8.4		25.2
Income tax expense	-2.9		-8.7
Other comprehensive income, net of income taxes	5.5		16.5
Pension and Post-Retirement Plan Benefit [Member] | Other Comprehensive Income (Loss) Before Reclassifications [Member]
Accumulated Other Comprehensive Income Loss Total [Roll Forward]
Pre-tax income	0		0
Income tax expense	0		0
Other comprehensive income, net of income taxes	0		0
Unrealized gain on available-for sale securities [Member]
Accumulated Other Comprehensive Income Loss Total [Roll Forward]
Beginning balance	176.4	143.8	121.2	94.6
Pre-tax income		37.2		115.9
Income tax expense		-14		-43.5
Other comprehensive income, net of income taxes	59.7	23.2	114.9	72.4
Ending balance	236.1	167	236.1	167
Unrealized gain on available-for sale securities [Member] | Reclassification out of Accumulated Other Comprehensive Income [Member]
Accumulated Other Comprehensive Income Loss Total [Roll Forward]
Pre-tax income	0		0
Income tax expense	0		0
Other comprehensive income, net of income taxes	0		0
Unrealized gain on available-for sale securities [Member] | Other Comprehensive Income (Loss) Before Reclassifications [Member]
Accumulated Other Comprehensive Income Loss Total [Roll Forward]
Pre-tax income	95.4		183.8
Income tax expense	-35.7		-68.9
Other comprehensive income, net of income taxes	$59.70		$114.90

Acquisitions_Narrative_Details

Acquisitions (Narrative) (Details) (USD $)	9 Months Ended
In Millions, unless otherwise specified	Sep. 27, 2013	Sep. 28, 2012
	Businesses
Business Combinations [Abstract]
Businesses acquired (businesses)	11
Cash paid for acquisitions	($868.60)	($972.80)
Aggregate annual sales of additional businesses	294
Goodwill related to acquisitions	$554

Acquisitions_Fair_Values_Of_Th

Acquisitions (Fair Values Of The Assets Acquired And Liabilities) (Details) (USD $)	Sep. 27, 2013
In Millions, unless otherwise specified
Business Acquisition [Line Items]
Trade accounts receivable	$78.10
Inventories	22.5
Property, plant and equipment	47.5
Goodwill	554
Other intangible assets, primarily trade names, customer relationships and patents	343.4
Trade accounts payable	-24.9
Other assets and liabilities, net	-130.5
Assumed debt	-21.2
Non-controlling interest acquired	-0.3
Net cash consideration	$868.60

Acquisitions_Results_Of_Operat

Acquisitions (Results Of Operations If Acquisition Was Consummated) (Details) (USD $)	3 Months Ended		9 Months Ended
In Millions, except Per Share data, unless otherwise specified	Sep. 27, 2013	Sep. 28, 2012	Sep. 27, 2013	Sep. 28, 2012
Business Combinations [Abstract]
Sales	$4,679.90	$4,558.90	$13,978.60	$13,771.90
Net earnings from continuing operations	$596.50	$551.30	$1,907.50	$1,685.10
Diluted net earnings per share from continuing operations	$0.84	$0.77	$2.69	$2.37

Sale_of_Joint_Venture_Narrativ

Sale of Joint Venture (Narrative) (Details) (USD $)	3 Months Ended		9 Months Ended		1 Months Ended	3 Months Ended		9 Months Ended	32 Months Ended
In Millions, except Per Share data, unless otherwise specified	Sep. 27, 2013	Sep. 28, 2012	Sep. 27, 2013	Sep. 28, 2012	Feb. 28, 2013	Mar. 29, 2013	Sep. 28, 2012	Sep. 28, 2012	Feb. 28, 2013
					Apex [Member]	Apex [Member]	Apex [Member]	Apex [Member]	Apex [Member]
Equity method investment, ownership percentage								50.00%	50.00%
Proceeds from sale of unconsolidated joint venture			$692	$0	$1,600
Total fair value of consideration received					797.1
Cash, including $66.6 of dividends received during 2013 prior to the closing of the sale					758.6				758.6
Note receivable					38.5				38.5
After-tax gain on sale of unconsolidated joint venture					143.6	143.6
Equity method investment realized gain on disposal per diluted share						$0.20
Earnings from unconsolidated joint venture	$0	$18.50	$0	$50.90	$0		$18.50	$50.90

Sale_of_Joint_Venture_Gain_Fro

Sale of Joint Venture (Gain From Affiliates) (Details) (USD $)	3 Months Ended		9 Months Ended		1 Months Ended	3 Months Ended
In Millions, unless otherwise specified	Sep. 27, 2013	Sep. 28, 2012	Sep. 27, 2013	Sep. 28, 2012	Feb. 28, 2013	Mar. 29, 2013
					Apex [Member]	Apex [Member]
Fair value of consideration received:
Proceeds from equity method investment, dividends or distributions					$66.60
Cash, including $66.6 of dividends received during 2013 prior to the closing of the sale					758.6
Note receivable					38.5
Total fair value of consideration received					797.1
Less book value of investment in unconsolidated joint venture					545.6
Less other related costs and expenses					21.7
Pre-tax gain on sale of unconsolidated joint venture	0	0	229.8	0	229.8
Income tax expense					86.2
After-tax gain on sale of unconsolidated joint venture					$143.60	$143.60

Discontinued_Operations_Narrat

Discontinued Operations (Narrative) (Details) (USD $)	3 Months Ended		9 Months Ended		3 Months Ended	12 Months Ended
In Millions, except Per Share data, unless otherwise specified	Sep. 27, 2013	Sep. 28, 2012	Sep. 27, 2013	Sep. 28, 2012	Mar. 30, 2012	Dec. 31, 2011
					ASI And KEO	ASI And KEO
Income Statement, Balance Sheet and Additional Disclosures by Disposal Groups, Including Discontinued Operations [Line Items]
Proceeds from sale of business			$0	$337.50	$337
Revenue of divested business	4,669.10	4,415.50	13,851.30	13,285.20		275
After-tax gain on sale of business					93.7
After-tax gain on sale of business, per diluted share (dollars per share)					$0.13
Loss from business during phase-out period, net of tax					$0.80

Goodwill_Rollforward_Of_Goodwi

Goodwill (Rollforward Of Goodwill) (Details) (USD $)	9 Months Ended
In Millions, unless otherwise specified	Sep. 27, 2013
Goodwill [Roll Forward]
Balance, December 31, 2012	$15,462
Attributable to 2013 acquisitions	554
Foreign currency translation & other	8.4
Balance, September 27, 2013	$16,024.40

Goodwill_Goodwill_By_Segment_D

Goodwill (Goodwill By Segment) (Details) (USD $)	Sep. 27, 2013	Dec. 31, 2012
In Millions, unless otherwise specified
Goodwill [Line Items]
Goodwill, carrying value	$16,024.40	$15,462
Test & Measurement
Goodwill [Line Items]
Goodwill, carrying value	3,206.50	3,222.10
Environmental
Goodwill [Line Items]
Goodwill, carrying value	1,844.90	1,554.90
Life Sciences & Diagnostics
Goodwill [Line Items]
Goodwill, carrying value	6,321.50	6,138.90
Dental
Goodwill [Line Items]
Goodwill, carrying value	2,185	2,168
Industrial Technologies
Goodwill [Line Items]
Goodwill, carrying value	$2,466.50	$2,378.10

Fair_Value_Measurements_Narrat

Fair Value Measurements (Narrative) (Details)	1 Months Ended	3 Months Ended		9 Months Ended
	Jan. 31, 2013	Sep. 27, 2013	Sep. 28, 2012	Sep. 27, 2013	Sep. 28, 2012	Sep. 27, 2013	Jan. 31, 2013
	USD ($)	USD ($)	USD ($)	USD ($)	USD ($)	Japanese Yen	Japanese Yen
						JPY (¥)	JPY (¥)
Fair Value Measurements [Line Items]
Japanese currency swap instruments bought, monthly basis (Japanese Yen)						¥ 92,000,000	¥ 184,000,000
Exchange rate of Japanese yen per United States dollar (US Dollars per Japanese Yen)						102.25
Notional amount of currency agreement terminated							6,000,000,000
Payments for termination of currency swap	10,000,000
Aggregate purchase commitment		52,000,000		52,000,000		5,100,000,000	11,900,000,000
Pre-tax (income) charge related to changes in the fair value of currency swap		$0	$2,000,000	($11,000,000)	($6,000,000)

Fair_Value_Measurements_Financ

Fair Value Measurements (Financial Assets And Liabilities Carried At Fair Value) (Details) (USD $)	Sep. 27, 2013	Dec. 31, 2012
In Millions, unless otherwise specified
Assets:
Available-for-sale securities, Assets	$537.30	$329.50
Liabilities:
Deferred compensation plans, Liabilities	67.9	64.5
Currency swap agreement, Liabilities	3.4	24.9
Quoted Prices In Active Market (Level 1)
Assets:
Available-for-sale securities, Assets	537.3	329.5
Liabilities:
Deferred compensation plans, Liabilities	0	0
Currency swap agreement, Liabilities	0	0
Significant Other Observable Inputs (Level 2)
Assets:
Available-for-sale securities, Assets	0	0
Liabilities:
Deferred compensation plans, Liabilities	67.9	64.5
Currency swap agreement, Liabilities	3.4	24.9
Significant Unobservable Inputs (Level 3)
Assets:
Available-for-sale securities, Assets	0	0
Liabilities:
Deferred compensation plans, Liabilities	0	0
Currency swap agreement, Liabilities	$0	$0

Fair_Value_Measurements_Carryi

Fair Value Measurements (Carrying Amounts And Fair Values Of Financial Instruments) (Details) (USD $)	Sep. 27, 2013	Dec. 31, 2012
In Millions, unless otherwise specified
Assets:
Available-for-sale securities	$537.30	$329.50
Liabilities:
Currency swap agreement	3.4	24.9
Carrying Amount
Assets:
Available-for-sale securities	537.3	329.5
Liabilities:
Short-term borrowings	56.5	55.5
Long-term borrowings	3,445.50	5,287.60
Currency swap agreement	3.4	24.9
Fair Value
Assets:
Available-for-sale securities	537.3	329.5
Liabilities:
Short-term borrowings	56.5	55.5
Long-term borrowings	3,901.10	5,917.30
Currency swap agreement	$3.40	$24.90

Financing_Transactions_Narrati

Financing Transactions (Narrative) (Details)

3 Months Ended

9 Months Ended

9 Months Ended

9 Months Ended

Share data in Millions, except Per Share data, unless otherwise specified

Sep. 27, 2013

Sep. 27, 2013

Sep. 28, 2012

Dec. 31, 2012

31-May-12

Sep. 27, 2013

Sep. 27, 2013

Dec. 31, 2012

Sep. 27, 2013

Sep. 27, 2013

Dec. 31, 2012

Sep. 27, 2013

Sep. 27, 2013

Sep. 27, 2013

Sep. 27, 2013

USD ($)

USD ($)

USD ($)

USD ($)

USD ($)

Eurobond Senior Notes

2013 Notes

2013 Notes

Liquid Yield Option Notes (LYONs)

Senior Notes Due Two Thousand Fourteen

Senior Notes Due Two Thousand Fourteen

Unsecured Revolving Credit Facility

U.S Commercial Paper

Commercial Paper [Member]

Euro-Denominated Commercial Paper [Member]

EUR (€)

USD ($)

USD ($)

USD ($)

USD ($)

USD ($)

USD ($)

USD ($)

USD ($)

Debt Instrument [Line Items]

Repayments of senior notes

$966,900,000

$3,400,000

-€ 500,000,000

($300,000,000)

Weighted average maturity of commercial paper

22 days

Shares issued under debt conversion (shares)

4.4

Common stock, par value (dollars per share)

$0.01

$0.01

$0.01

$0.01

Deferred tax liability, basis difference in LYONs

41,000,000

Weighted average interest rate of short-term debt (interest rate)

0.10%

Commercial paper

450,000,000

450,000,000

1,224,500,000

0

Senior notes

0

300,000,000

400,000,000

400,000,000

Interest rate of debt instrument

4.50%

1.30%

Borrowings outstanding under credit facility

0

Line of credit

$2,500,000,000

Financing_Transactions_Compone

Financing Transactions (Components Of Debt) (Details)

Sep. 27, 2013

Dec. 31, 2012

Sep. 27, 2013

Sep. 27, 2013

Dec. 31, 2012

Dec. 31, 2012

Sep. 27, 2013

Dec. 31, 2012

Sep. 27, 2013

Dec. 31, 2012

Sep. 27, 2013

Dec. 31, 2012

Sep. 27, 2013

Dec. 31, 2012

Sep. 27, 2013

Dec. 31, 2012

Sep. 27, 2013

Dec. 31, 2012

Sep. 27, 2013

Dec. 31, 2012

In Millions, unless otherwise specified

USD ($)

USD ($)

Eurobond Senior Notes

Eurobond Senior Notes

Eurobond Senior Notes

Eurobond Senior Notes

2013 Notes

2013 Notes

Senior Notes Due Two Thousand Fourteen

Senior Notes Due Two Thousand Fourteen

2016 Notes

2016 Notes

2018 Notes

2018 Notes

2019 Notes

2019 Notes

2021 Notes

2021 Notes

Zero-Coupon LYONs

Zero-Coupon LYONs

USD ($)

EUR (€)

USD ($)

EUR (€)

USD ($)

USD ($)

USD ($)

USD ($)

USD ($)

USD ($)

USD ($)

USD ($)

USD ($)

USD ($)

USD ($)

USD ($)

USD ($)

USD ($)

Debt Instrument [Line Items]

Commercial paper

$450

$1,224.50

Other notes payable

0

0

659.8

500

Senior notes

0

300

400

400

500

500

500

500

750

750

600

600

Zero-coupon LYONs due 2021

159.4

281.4

Other

142.6

127.4

Subtotal

3,502

5,343.10

Less - current portion

56.5

55.5

Long-term debt

$3,445.50

$5,287.60

Interest rate of debt instrument

4.50%

4.50%

1.30%

2.30%

5.63%

5.40%

3.90%

0.00%

Defined_Benefit_Plans_Narrativ

Defined Benefit Plans (Narrative) (Details) (Non-U.S. Pension Benefits, USD $)	Sep. 27, 2013
In Millions, unless otherwise specified
Non-U.S. Pension Benefits
Defined Benefit Plan Disclosure [Line Items]
Expected cash contribution requirements by employer	$52

Defined_Benefit_Plans_Componen

Defined Benefit Plans (Components Of Net Periodic Benefit Cost) (Details) (USD $)	3 Months Ended		9 Months Ended
In Millions, unless otherwise specified	Sep. 27, 2013	Sep. 28, 2012	Sep. 27, 2013	Sep. 28, 2012
U.S. Pension Benefits
Defined Benefit Plan Disclosure [Line Items]
Service cost	$1.40	$1.30	$4.20	$4.30
Interest cost	25	26	72.4	75.8
Expected return on plan assets	-31.2	-32.8	-94	-97.2
Amortization of actuarial loss	8.6	12.7	22.6	31.7
Net periodic benefit cost	3.8	7.2	5.2	14.6
Non-U.S. Pension Benefits
Defined Benefit Plan Disclosure [Line Items]
Service cost	6.7	5.9	19.9	17.5
Interest cost	10.4	10.7	31.2	32.2
Expected return on plan assets	-8.4	-8.1	-25.5	-24.4
Amortization of actuarial loss	1.9	1.1	5.9	3.4
Amortization of prior service credit	-0.1	-0.1	-0.3	-0.3
Settlement losses recognized	0	0	0.6	0.9
Net periodic benefit cost	10.5	9.5	31.8	29.3
Other Post-Retirement Benefits
Defined Benefit Plan Disclosure [Line Items]
Service cost	0.3	0.3	1.1	1.3
Interest cost	2	2.4	6	7.8
Amortization of actuarial loss	0.2	0.4	1	2.4
Amortization of prior service credit	-1.7	-1.4	-5	-4.2
Net periodic benefit cost	$0.80	$1.70	$3.10	$7.30

Stock_Transactions_And_StockBa2

Stock Transactions And Stock-Based Compensation (Narrative) (Details) (USD $)	3 Months Ended	9 Months Ended
In Millions, except Share data, unless otherwise specified	Sep. 27, 2013	Sep. 27, 2013	Sep. 28, 2012	Jul. 16, 2013	Dec. 31, 2012	31-May-12	9-May-12
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Common stock, shares authorized (shares)						2,000,000,000	1,000,000,000
Common stock, par value (dollars per share)	$0.01	$0.01			$0.01	$0.01
Stock repurchased during period, shares	0	0
Stock repurchase program, authorized shares to be repurchased				20,000,000
Stock repurchase program, remaining number of shares authorized to be repurchased	20,000,000	20,000,000
Common shares reserved for issuance under the 2007 Stock Incentive Plan (shares)	29,000,000	29,000,000
Aggregate intrinsic value of options exercised		$136	$161
Cash receipts due to exercise of options		134	146
Tax benefit realized related to exercise of stock options	12	43
Tax benefit related to the vesting of restricted stock units	12	26
Total number of shares withheld sufficient to fund minimum tax withholding requirements related to the vesting of restricted stock units (shares)		496,000
Total value of shares withheld sufficient to fund minimum tax withholding requirements related to the vesting of restricted stock units		32
Restricted Stock Units (RSUs)
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Total unrecognized compensation cost	162	162
Weighted average period for cost to be recognized (in years)		3 years
Stock Options
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Total unrecognized compensation cost	$145	$145
Weighted average period for cost to be recognized (in years)		3 years

Stock_Transactions_And_StockBa3

Stock Transactions And Stock-Based Compensation (Assumptions Used In The Black-Scholes Model To Value Options Granted) (Details)	9 Months Ended
	Sep. 27, 2013
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Weighted average volatility (percentage)	23.60%
Dividend yield (percentage)	0.20%
Minimum
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Risk-free interest rate (percentage)	0.98%
Expected years until exercise (years)	6 years
Maximum
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Risk-free interest rate (percentage)	2.33%
Expected years until exercise (years)	8 years 6 months

Stock_Transactions_And_StockBa4

Stock Transactions And Stock-Based Compensation (Components Of Stock-Based Compensation Program) (Details) (USD $)	3 Months Ended		9 Months Ended
In Millions, unless otherwise specified	Sep. 27, 2013	Sep. 28, 2012	Sep. 27, 2013	Sep. 28, 2012
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Pre-tax compensation expense	$29.60	$29	$85.70	$79.40
Income tax benefit	-8.9	-8.9	-26	-25.1
Stock-based compensation expense, net of income taxes	20.7	20.1	59.7	54.3
Restricted Stock Units (RSUs)
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Pre-tax compensation expense	17.6	16	49.9	43.2
Income tax benefit	-5.2	-4.9	-15	-14.1
Stock-based compensation expense, net of income taxes	12.4	11.1	34.9	29.1
Stock Options
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Pre-tax compensation expense	12	13	35.8	36.2
Income tax benefit	-3.7	-4	-11	-11
Stock-based compensation expense, net of income taxes	$8.30	$9	$24.80	$25.20

Stock_Transactions_And_StockBa5

Stock Transactions And Stock-Based Compensation (Option Activity Under The Company's Stock Plans) (Details) (USD $)	9 Months Ended
In Thousands, except Per Share data, unless otherwise specified	Sep. 27, 2013
Share-based Compensation Arrangement by Share-based Payment Award, Options, Outstanding [Roll Forward]
Outstanding as of December 31, 2012, Options (shares)	27,372
Granted, Options (shares)	3,609
Exercised, Options (shares)	-4,317
Cancelled/forfeited, Options (shares)	-866
Outstanding as of September 27, 2013, Options (shares)	25,798
Outstanding as of December 31, 2012, Weighted Average Exercise Price (dollars per share)	$37.94
Granted, Weighted Average Exercise Price (dollars per share)	$64.43
Exercised, Weighted Average Exercise Price (dollars per share)	$31.12
Cancelled/forfeited, Weighted Average Exercise Price (dollars per share)	$44.41
Outstanding as of September 27, 2013, Weighted Average Exercise Price (dollars per share)	$42.57
Outstanding as of September 27, 2013, Weighted Average Remaining Contractual Term (in years)	6 years
Outstanding as of September 27, 2013, Aggregate Intrinsic Value	$704,366
Vested and Expected to Vest as of September 27, 2013, Options (shares)	25,028	[1]
Vested and Expected to Vest as of September 27, 2013, Weighted Average Exercise Price (dollars per share)	$42.15	[1]
Vested and Expected to Vest as of September 27, 2013, Weighted Average Remaining Contractual Term (in years)	6 years	[1]
Vested and Expected to Vest as of September 27, 2013, Aggregate Intrinsic Value	693,732	[1]
Vested as of September 27, 2013, Options (shares)	13,732
Vested as of September 27, 2013, Weighted Average Exercise Price (dollars per share)	$34.99
Vested as of September 27, 2013, Weighted Average Remaining Contractual Term (in years)	4 years
Vested as of September 27, 2013, Aggregate Intrinsic Value	$479,041
[1]	The bExpected to Vestb options are the net unvested options that remain after applying the pre-vesting forfeiture rate assumption to total unvested options.

Stock_Transactions_And_StockBa6

Stock Transactions And Stock-Based Compensation (RSU And Restricted Shares Activity) (Details) (USD $)	9 Months Ended
In Thousands, except Per Share data, unless otherwise specified	Sep. 27, 2013
Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Nonvested [Roll Forward]
Unvested as of December 31, 2012, Number of RSUs/Restricted Shares (shares)	5,585
Granted, Number of RSUs/Restricted Shares (shares)	1,531
Vested, Number of RSUs/Restricted Shares (shares)	-1,332
Forfeited, Number of RSUs/Restricted Shares (shares)	-450
Unvested as of September 27, 2013, Number of RSUs/Restricted Shares (shares)	5,334
Unvested as of December 31, 2012, Weighted Average Grant-Date Fair Value (dollars per share)	$43.29
Granted, Weighted Average Grant-Date Fair Value (dollars per share)	$64.54
Vested, Weighted Average Grant-Date Fair Value (dollars per share)	$37.63
Forfeited, Weighted Average Grant-Date Fair Value (dollars per share)	$44.86
Unvested as of September 27, 2013, Weighted Average Grant-Date Fair Value (dollars per share)	$50.67

Restructuring_And_Other_Relate2

Restructuring And Other Related Charges (Narrative) (Details) (USD $)	12 Months Ended
In Millions, unless otherwise specified	Dec. 31, 2012
Restructuring Charges [Abstract]
Restructuring and other related charges recorded	$123

Restructuring_And_Other_Relate3

Restructuring And Other Related Charges (Accrual Balance And Utilization Of Restructuring Cost) (Details) (USD $)	9 Months Ended
In Millions, unless otherwise specified	Sep. 27, 2013
Restructuring Reserve [Roll Forward]
Balance as of December 31, 2012	$103.70
Paid/Settled	-77.3
Balance as of September 27, 2013	26.4
Employee severance and related
Restructuring Reserve [Roll Forward]
Balance as of December 31, 2012	96.9
Paid/Settled	-72.2
Balance as of September 27, 2013	24.7
Facility exit and related
Restructuring Reserve [Roll Forward]
Balance as of December 31, 2012	6.8
Paid/Settled	-5.1
Balance as of September 27, 2013	$1.70

Contingencies_Narrative_Detail

Contingencies (Narrative) (Details)	9 Months Ended
	Sep. 27, 2013
Commitments and Contingencies Disclosure [Abstract]
Warranty period terms minimum (days)	90 days
Warranty period terms maximum	the life of the product

Contingencies_Warranty_Accrual

Contingencies (Warranty Accrual) (Details) (USD $)	9 Months Ended
In Millions, unless otherwise specified	Sep. 27, 2013
Movement in Standard and Extended Product Warranty, Increase (Decrease) [Roll Forward]
Balance, December 31, 2012	$140.70
Accruals for warranties issued during the period	109.6
Settlements made	-106.9
Additions due to acquisitions	2.6
Effect of foreign currency translation	-0.4
Balance, September 27, 2013	$145.60

Net_Earnings_Per_Share_From_Co2

Net Earnings Per Share From Continuing Operations (Narrative) (Details)	3 Months Ended		9 Months Ended
	Sep. 27, 2013	Sep. 28, 2012	Sep. 27, 2013	Sep. 28, 2012
Earnings Per Share [Abstract]
Options excluded from diluted earnings per share calculation (anti-dilutive) (shares)	0	2,000,000	1,000,000	2,000,000

Net_Earnings_Per_Share_From_Co3

Net Earnings Per Share From Continuing Operations (Components Of Basic And Diluted Earnings Per Share) (Details) (USD $)	3 Months Ended		9 Months Ended
In Millions, except Per Share data, unless otherwise specified	Sep. 27, 2013	Sep. 28, 2012	Sep. 27, 2013	Sep. 28, 2012
Earnings Per Share [Abstract]
Basic EPS, Net Earnings From Continuing Operations (Numerator)	$597	$548.70	$1,905.70	$1,668.90
Basic EPS, Shares (Denominator) (shares)	697.7	695.2	695	694.1
Basic EPS, Per Share Amount (dollars per share)	$0.86	$0.79	$2.74	$2.40
Adjustment for interest on convertible debentures, Net Earnings From Continuing Operations (Numerator)	0.6	1.4	2.6	4.4
Incremental shares from assumed exercise of dilutive options and vesting of dilutive RSUs, Shares (Denominator) (shares)	8.6	8.4	8.5	9.9
Incremental shares from assumed conversion of the convertible debentures, Shares (Denominator) (shares)	5.6	10.3	6.6	10.3
Diluted EPS, Net Earnings From Continuing Operations (Numerator)	$597.60	$550.10	$1,908.30	$1,673.30
Diluted EPS, Shares (Denominator) (shares)	711.9	713.9	710.1	714.3
Diluted EPS, Per Share Amount (dollars per share)	$0.84	$0.77	$2.69	$2.34

Segment_Information_Segment_Re

Segment Information (Segment Results) (Details) (USD $)	3 Months Ended		9 Months Ended
In Millions, unless otherwise specified	Sep. 27, 2013	Sep. 28, 2012	Sep. 27, 2013	Sep. 28, 2012
			Business_Segments
Segment Reporting Information [Line Items]
Number of segments reported (Business Segments)			5
Sales	$4,669.10	$4,415.50	$13,851.30	$13,285.20
Operating Profit	812.4	755.8	2,386.90	2,302
Test & Measurement
Segment Reporting Information [Line Items]
Sales	808.6	814.5	2,519	2,517.30
Operating Profit	155	163.6	520.7	539.4
Environmental
Segment Reporting Information [Line Items]
Sales	828.7	754.4	2,380.80	2,212.90
Operating Profit	171.6	162.4	485.6	456.6
Life Sciences & Diagnostics
Segment Reporting Information [Line Items]
Sales	1,675.10	1,518.10	4,916.80	4,647.40
Operating Profit	246.8	185.6	686.8	599.4
Dental
Segment Reporting Information [Line Items]
Sales	510.2	488.9	1,504.70	1,452.40
Operating Profit	82.2	76	223.9	206.5
Industrial Technologies
Segment Reporting Information [Line Items]
Sales	846.5	839.6	2,530	2,455.20
Operating Profit	191.7	183.5	566.7	531.6
Equity method earnings of Apex joint venture
Segment Reporting Information [Line Items]
Operating Profit	0	18.5	0	50.9
Other
Segment Reporting Information [Line Items]
Operating Profit	($34.90)	($33.80)	($96.80)	($82.40)